Washing-resistant surfactant coated surface is able to inhibit pathogenic bacteria adhesion  by Treter, Janine et al.
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a  b  s  t  r  a  c  t
Surface-active  substances,  which  are  able  to  organize  themselves  spontaneously  on  surfaces,  trigger-
ing changes  in the nature  of  the  solid–liquid  interface,  are  likely  to  inﬂuence  microorganism  adhesion
and  bioﬁlm  formation.  Therefore,  this  study  aimed  to evaluate  chemical  non-ionic  surfactants  activity
against  pathogenic  microbial  bioﬁlms  and  to  cover  biomaterial  surfaces  in  order  to  obtain  an anti-infective
surface.  After  testing  11  different  surfactants,  Pluronic  F127  was  selected  for further  studies  due  to  its
non-biocidal  properties  and  capability  to  inhibit  up to  90%  of  bioﬁlm  formation  of  Gram-positive  pathogen
and  its  clinical  isolates.  The  coating  technique  using  direct  impregnation  on the  surface  showed  impor-
tant  antibioﬁlm  formation  characteristics,  even  after  extensive  washes.  Surface  roughness  and  bacterialluronic F127
taphylococcus epidermidis
surface  polarity  does  not  inﬂuence  the  adhesion  of Staphylococcus  epidermidis,  however,  the  material
coated  surface  became  extremely  hydrophilic.  The  phenotype  of S. epidermidis  does  not  seem to  have
been  affected  by  the contact  with  surfactant,  reinforcing  the evidence  that  a physical  phenomenon  is
responsible  for the  activity.  This paper  presents  a simple  method  of  surface  coating  employing  a  synthetic
surfactant  to  prevent  S. epidermidis  bioﬁlm  formation.
© 2014  Elsevier  B.V.  All  rights  reserved.. Introduction
Bioﬁlms are microbial aggregates which develop adhered to sur-
aces. The surface of an implantable medical device becomes an
deal environment for bacterial adhesion, and consequently bioﬁlm
ormation process. Nowadays, it is well accepted in the scientiﬁc
iterature that the way of life adopted by most of the bacteria is in
he bioﬁlm form [1]. This way of life is ubiquitous in the environ-
ent, and plays a role in the pathogenesis of infectious processes
2]. About 80% of medical infections are associated to bioﬁlm forma-
ion [3]. Such infections complicate the clinical course of patients,
nd create substantial economic and human costs [4,5]. It is esti-
ated that 60–70% of medical infections are associated with some
iomedical device [6]. These devices are conceptually known as an
∗ Corresponding author at: Faculdade de Farmácia, Universidade Federal do Rio
rande do Sul, Rio Grande do Sul, Brazil. Av. Ipiranga, 2752, 90610-000, Porto Alegre,
razil. Tel.: +55 51 33086082; fax: +55 51 33087309.
E-mail address: alexandre.macedo@ufrgs.br (A.J. Macedo).
ttp://dx.doi.org/10.1016/j.apsusc.2014.02.123
169-4332/© 2014 Elsevier B.V. All rights reserved.apparatus composed of a biomaterial, commonly polymeric mate-
rials such as poly(dimethyl siloxane), polyethylene, poly(methyl
methacrylate), polyvinyl chloride, polystyrene, among others [7].
The abiotic surface of an implantable/inserted device such as
cardiac valves, stents, vascular and urinary catheters, joint prosthe-
ses and others becomes ideal environment for providing bacterial
adhesion, the ﬁrst step of bioﬁlm formation [7–9]. Once a bacterium
is attached, a multi-step process starts, resulting in a microbial
community embedded in a self-produced matrix, a bioﬁlm [10,11].
Bacteria living in this complex way of life are notably more resistant
to antibiotics and the host immune system [12,13]. Staphylococcus
sp. and Pseudomonas aeruginosa are the most common pathogens
associated with infections [14]. Staphylococci are currently the
most common cause of nosocomial infections [15], whereas P.
aeruginosa, an opportunistic pathogen, possessing many virulence
factors, is the mostly responsible for infections on cystic ﬁbrosis
patients [16].
The surface chemistry and topography affect biological
responses, and are of fundamental importance, especially
when living systems (bacteria) encounter synthetic surfaces
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biomaterial) [17,18]. In recent years, intensive efforts have been
ocused on improving the performance of existing surfaces, as
he application of coatings, or surfaces architecture modiﬁcation
nd/or alteration, procedures that advantageously ensure the same
iomaterial bulk properties [19–21]. The ability of bioﬁlms to
dhere to surfaces led us to explore the use of surface-active sub-
tances, molecules inherently capable of position themselves in
urfaces and interfaces.
Surfactants or surface active-compounds, both chemical and
iological, are amphipathic compounds containing hydrophilic
nd hydrophobic moieties, which confer the capability of auto-
rganization between phases, reducing interfacial tensions and
orming aggregates such as micelles [22]. This spontaneous process
eads to a drastic change in the surface nature, directly affecting the
dhesion of microorganisms [23]. Surfactants are classiﬁed accord-
ng to their ionic properties in water (anionic, cationic, non-ionic,
nd amphoteric) and are used in a wide range of industrial applica-
ions, such as pharmaceutical, therapeutic and cosmetic products
24]. It is well established in the literature that poly(ethylene
xide) (PEO) coatings, are a promising method to avoid infections
ince these macromolecules have the capability to self-assemble
n the material surface, juts outwards the PEO chains acting like a
arrier between the microorganism and the surface [25]. This self-
ssemble phenomenon allows a comparison between PEO chains
nd lumps of a brush, thus PEO coatings are widely called as brush
oatings.
Given the high levels of bioﬁlm infection and the emergence
f antibiotic-resistant bacteria combined with the slow progress
n identifying new antimicrobial agents, combat strategies have
nestimable clinical value. In this sense, the aim of this study was
o search for antibioﬁlm activity of distinct nonionic surfactants
ontaining PEO chains in order to obtain a surface covered less
usceptible to bacterial adhesion.
. Experimental
.1. Surface-active compounds and material
Synthetic chemical surfactants were supplied by Sigma–Aldrich
razil: Span® 40, Span® 60, Span® 80; Tween® 20, Tween®
0, Tween® 60, Tween® 80; Pluronic® F127, Pluronic® F68;
yloxapol®, Triton X®-100. As material model, polystyrene 96-well
icroplates (COSTAR, 3599) and PERMANOXTM slides (NUNC, USA),
 polystyrene modiﬁed polymer acetone resistant, were used.
.2. Bacterial strains and culturing
All strains, Staphylococcus epidermidis ATCC 35984, Pseudomonas
eruginosa ATCC 27853 and 11 S. epidermidis clinical isolates were
rown aerobically at 37 ◦C for 24 h on Mueller Hinton agar (OXOID,
ngland) plates from frozen stocks. A bacterial suspension was
et in sterile sodium chloride 0.9% to a ﬁnal concentration of
 × 108 colony-forming unit per mL  (CFU/mL) following McFar-
and standard was prepared (in practical terms, 80 L = OD600
.090 ± 0.03). The clinical strains assayed (50, 73, 92, 113, 117, 122,
24a, 183b, 196, 228 and 229) were isolated from central venous
atheters of patients of a Hospital in Porto Alegre between January
008 and May  2009 [15].
.3. Antibiotic, antibioﬁlm formation and bioﬁlms eradication
ssaysIn a 96-well microplate, optical density at 600 nm (OD600) and
rystal violet dye method were employed to measure bacterial
rowth and bioﬁlm formation, respectively [26]. Brieﬂy, in eachience 303 (2014) 147–154
well was added 80 L of the surfactant solution, 80 L of the bac-
terial suspension and 40 L of tryptone soya broth (TSB) (OXOID,
England). A control without surfactant treatment was carried out
for microbial growth control and bioﬁlm formation, the 100%. Non-
inoculated TSB was  included as a contamination standard. Before
and after the incubation period at 37 ◦C the absorbance in 600 nm
was measured to quantify the bacterial growth. For bioﬁlm for-
mation, after the incubation period of 24 h for Staphylococci and
6 h for Pseudomonas, the well content was removed and each well
was washed three times with saline to remove planktonic cells, fol-
lowed by a one hour bioﬁlm ﬁxation process at 60 ◦C. After that,
200 L of crystal violet dye was added at each well for 15 min.
To ensure removal of dye excess a washing process in running
water was  performed. The stained bioﬁlm or adherent cells were
extracted with 200 L of dimethylsulfoxide 99.9% and then, the
absorbance was measured in 570 nm.
The ability of surfactants to eradicate already formed bioﬁlms
was measured by adding 120 L of TSB and 80 L of inoculum to a
polystyrene plate. After 24 h of Staphylococcus epidermidis bioﬁlm
formation at 37 ◦C in aerobic atmosphere, the supernatant was
carefully removed in a laminar ﬂow to prevent the disruption of
the bioﬁlm formed in the well. After, 120 L of TSB and 80 L sur-
factant solutions (0.5%) or water (control) were added. After 24 h
incubation, the eradication ability of the test surfactant was  esti-
mated according to the crystal violet staining assay. All assays were
performed in six replicates and biological triplicates.
2.4. Impregnation methodologies and washing assays
2.4.1. Surface activation by ionic plasma discharge followed by
impregnation
Surface activation attempts were made in the polystyrene sur-
face by an argon plasma discharge. The process was carried out
in a cylindrical plasma-reactor made of stainless steel, equipped
with a direct current power supply, a vacuum system and a gas
reservoir. In order to minimize thermal effects on the sample, the
sample holder was kept at a value two thirds below the glass transi-
tion temperature of polystyrene (95 ◦C) throughout the treatment
period.
Polystyrene microplates were inserted in the vacuum chamber,
which was  pressurized to a base pressure of 2 × 10−2 mBar. Radio
frequency source was  kept at 13.56 MHz  with a pressure of 0.6 mBar
argon atmosphere (purity >99.999%), to generate the plasma ion. It
was estimated that the atoms reach the surface with a power of
100 W for a 2 min  treatment period. After depressurization of the
chamber, samples were immediately subjected to impregnation
with Pluronic F127 solutions. The controls for the plasma treat-
ment were conducted exposing polystyrene samples only to argon
gas.
Immediately after plasma treatment, the surface was covered
with aqueous surfactant solution and left at 60 ◦C for 24 h. To ensure
the stability of the impregnation process, the microplate wells were
washed 150 times. The washing procedure was  realized manually
using a micropipette under laminar ﬂow, with ultrapure sterile
water as washing liquid.
2.4.2. Direct impregnation of the surface
Polystyrene 96-well microplates were directly impregnated
(covered) with two  different solutions containing Pluronic F127.
The surface was  treated for 12 h at room temperature with Pluronic
F127 on laminar ﬂow in: (1) aqueous solution and (2) ethanolic
solution. Since ethanol is a volatile solvent, after its evapora-
tion occurs a surfactant deposition and the surface becomes dry.
To ensure the impregnation process stability of both surfaces,
microplate wells were washed according to a sequence of 100
washing steps with two  different liquids, MilliQ sterile water and
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terile Phosphate Buffer Saline (PBS) pH 7.4. No washing was  car-
ied out in the control test.
.5. Scanning electron microscopy (SEM)
PERMANOXTM cell culture slides samples (1.0 cm × 0.5 cm)  were
ncubated with S. epidermidis exposed to the surfactant for 24 h at
7 ◦C as previously described [26]. In brief, the incubation period
as followed by a twice wash with sterile 0.9% sodium chloride to
emove free bacterial cells and ﬁxed for 3 h in glutaraldehyde 2.5%.
hen, the samples were washed with 100 mM of sodium cacodylate
uffer (pH 7.2) and lastly dehydrated using acetone concentrations
arying from 30 to 100%. The dehydrated polymer pieces were dried
y the CO2 critical point technique (CPD 030 Balzers, Liechtenstein),
xed on aluminum stubs, gold metallized and examined in a JEOL
SM-6060 scanning electron microscope.
.6. Critical micellar concentration determination
Critical micelle concentration (CMC) is the concentration of an
mphiphilic component in the bulk solution at which the for-
ation of micelles is initiated. CMC  were estimated using the
ater-insoluble dye 1-(2-pyridylazo)-2-naphthol (PAN) technique
s previously described [27]. Brieﬂy, 38 L of a 1.6 mM PAN pen-
ane solution was added to 200 L of aqueous solutions of Pluronic
127 at concentrations ranging from 1.53 × 10−5 to 4.0% (w/v). The
ixture was shaken vigorously and left stand for 30 min. Aliquots
f each aqueous solution (100 L) were transferred to a 96-well
icroplate and the absorbance was measured at 470 nm. From the
bsorbance results the logarithm of the Pluronic F127 concentra-
ion was plotted and the CMC  value determined as the inﬂection
oint. All measurements were made in duplicate, and the CMC  was
stimated as the mean value of three experimental data.
.7. Hydrophobicity index (HPBI)
Interference of Pluronic F127 on the Staphylococci cells was
easured by the assay of afﬁnity of bacterial cell for hydrocar-
on as previously described [28]. In brief, 8 mL  of the aqueous
ample of surfactant (0.003, 0.1 and 0.68%) were added in a ster-
le falcon followed by 4 mL  of bacterial suspension (80 L = OD600
.090 ± 0.03) in saline and 4 mL  of TSB (OXOID, England). The test
ontrol used water instead of surfactant solution. After 24 h at
7 ◦C in static condition, the mixture was centrifuged for 10 min
t 10,000 rpm. The cells were rinsed three times with sterile
aline to remove possible amount of surfactant adsorbed and then,
esuspended to 200 L = OD600 0.3 (ODinitial). A volume of 3 mL
f this adjusted cell suspension was added to 500 L of toluene
nd vortexed for 1 min. Ultimately, after 30 min  at room tem-
erature the suspension completely separated phases, and the
queous OD600 was measured (ODﬁnal). The HBPI was  calculated
s: (ODinitial − ODﬁnal)/ODﬁnal × 100%. Bacteria with an HBPI > 70%
as classiﬁed as hydrophobic, arbitrarily [29].
.8. Surfactant inﬂuence estimation on the S. epidermidis
henotype
The surfactant ability to adsorb on the pathogen surface and/or
nﬂuence on the phenotype was estimated by a microorganism
re-inoculum treatment with a surfactant solution. Brieﬂy, 8 mL of
terile ultrapure water (control) or surfactant solution, 8 mL  of bac-
erial suspension OD600 0.150 ± 0.03 (pre-inoculum) and 4 mL  of
SB were added in a sterile tube. After 24 h at 37 ◦C under static
onditions, the pre-inoculum was centrifuged at 10,000 rpm for
0 min. The supernatant from the centrifugation was  discarded and
he bacterial cell pellet was resuspended in sterile 0.9% saline andience 303 (2014) 147–154 149
centrifuged again. This process was  repeated three times to remove
excess surfactant solution adsorbed to bacterial cells. The washed
pellet was then resuspended in 0.9% sterile saline to an OD600
0.150 ± 0.03 (inoculums). The inﬂuence of pre-inoculum treatment
was estimated by the ability of the microorganism to form bioﬁlm
undergo to a previous contact with the surfactant solution.
2.9. Surface characterization
2.9.1. Atomic force microscopy (AFM)
Non-contact atomic force microscopy (AFM) was carried out
with an AFM Nanoscope III device. A silicon arrow-NC-10 AFM
probe was  used and measurements were made at random sites.
A spring constant of 42 N/m and a resonance frequency of 285 Hz
were used for scanning. As a result, a mean roughness (Ra) param-
eter was  provided.
2.9.2. Contact angle measurements
The contact angle of 2 L sessile droplets was measured at two
locations on each sample using a custom-made device at room
temperature and distilled water as solvent. A mean contact angle
was obtained from at least 3 measurements. Images were taken
immediately after the droplet reached the surface with DinoCap-
ture 2.0 Version 1.3.8. Image processing to obtain angle values were
performed with the software Surftens 3.0.
3. Results and discussion
Synthetic polymeric materials such as silicon, polystyrene,
polyurethane and polyethylene are widely used in medicine and
biotechnology [7]. As a common feature, they share a hydrophobic
nature, which makes them prone to nonspeciﬁc adsorption of pro-
teins and bacteria [20]. Bacterial adhesion to a surface followed by
bioﬁlm formation is a major cause of chronic infections [12]. Due to
the chemical structure and the favorable trend by agglomerating on
surfaces, surfactants become potential molecules able to interfere
with microbial adhesion and subsequent bioﬁlm formation [22].
Polystyrene, a rigid, transparent, and hydrophobic thermoplastic
material was  used as a model.
Among all surfactants tested at concentrations between 0.025
and 0.5%, the bioﬁlm formation of S. epidermidis was remarkably
avoided with Pluronic F127 treatments. The inhibition reaches
approximately 95% at all concentrations tested without killing the
bacterium, whose cellular viability was higher than that of the
control without Pluronic F127 treatment (100%) (Table S1). It is
believed that this kind of strategy shows a promising potential,
since the inhibition of bioﬁlm formation by a non-biocidal pro-
cess differs from antibiotics and biocides antiseptic agents, which
may  be toxic and promote the development of resistance [30],
representing a safe and effective alternative to control infection.
Bridgett et al. [25] observed anti-adhesive proﬁle similar to a
series of Pluronics, among them, F127 and F68, where a clinical
isolate of S. epidermidis, remained viable during the treatments.
Yet, differently from our results, Pluronic F68 showed better anti-
adhesive characteristics, compared to the F127 on the polystyrene
surface.
Regarding antibiotic activity, expressed as percentage of bacte-
rial growth, Table S1 shows a concentration independent behavior
(0.025–0.5%). For most of the surfactants tested, no loss in S. epi-
dermidis growth was observed, except for Triton X-100 and Span
80. This result was expected for Triton X-100, a surfactant widely
used as a lysing agent in cytotoxicity assays [31]; however, no stud-
ies comprising the antibiotic activity of Span 80 were found in the
literature.
For P. aeruginosa,  a Gram-negative bacteria model, none of the
surfactants tested were able to interfere with bioﬁlm formation
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Table S2). It is known that P. aeruginosa is difﬁcult to combat and
otentially resistant to antimicrobials, mainly due to its ability to
utate into different loci [32,33]. Previous studies with Pluronic
127 and P. aeruginosa have suggested a lack of activity as a result
f cell surface hydrophobicity of the pathogen [9,34].
Attempts to combat already formed and mature bioﬁlms were
lso carried out with surfactants. Because of the complexity and
tability of a mature bioﬁlm, the highest concentration of 0.5% was
pplied (Table S3). The results obtained in this study conﬁrm lit-
rature reports that highlight the difﬁculty to ﬁnd substances that
reak, penetrate and eradicate a mature bioﬁlm. Among some rea-
ons for the high rates of mature bioﬁlms resistance are low growth
ate in cells in bioﬁlms; antimicrobial inefﬁciency by low penetra-
ion in the bioﬁlm due to the presence of extracellular polymeric
atrix that surrounds the cells, altered metabolism as efﬂux pumps
nd responses to stress [12], and also the presence of “persisters”
ells that are dormant, highly tolerant to antibiotics [2,35].
In order to proceed and reﬁne our work, Pluronic group was
elected against the Gram-positive cocci S. epidermidis, a com-
ensal microorganism that commonly causes infections associated
ith medical devices [5,36]. Based on the literature, it was found
hat triblock copolymers are able to self-organize on surfaces, form-
ng structures such as polymeric brushes [37]. These structures
an be covalently attached or only physically adsorbed to the sub-
trate, both procedures are part of the “grafting to” approach. The
opolymer is grafted on the biomaterial surface, that is desired
nti-infective properties [38]. It is believed that pluronic molecules
dhere to a hydrophobic surface via hydrophobic POP chain,
hereas hydrophilic chains of PEO are designed for the hydrophilic
edia [25]. POE chains form a steric layer and also the absence
f ionic charge, high hydrophilicity, ﬂexibility and mobility of this
ayer in aqueous environment are able to prevent the adsorption of
roteins and microorganisms [39].
The middle concentration employed in the screening (0.1%) was
dopted to challenge clinical isolates of S. epidermidis for antibiotic
nd antibioﬁlm formation activities (Fig. 1). Similar activities were
bserved between ATCC strain and clinical isolates. Pluronic F127
as capable to inhibit bioﬁlm formation without killing the bac-
erium for most isolates, except for isolate 183b, which presented
bout 25% of antibiotic activity, a pattern previously reported by
ur research group [40].
Due to the remarkable capacity of Pluronic 127 to prevent
taphylococcal adhesion, this substance was chosen for further
tudies. Unlike Pluronic F127, F68 0.1% showed no antibioﬁlm for-
ation activity against most clinical isolates on polystyrene, but
t shares the absence of biocide characteristics. We  suggest that
he proportion of the nonpolar portion over the polar is responsi-
le for the phenomenon observed as well as the size of the polar
ortion which should be large enough to generate a protective
arrier. Elsewhere was suggested that as higher the polar chain
ength, smaller the number of adherent bacteria [41], which are
wo possible explanations for the remarkable non-adherent capa-
ility of Pluronic F127 (99/67/99 PEO/POP/PEO) compared to the
68 (76/30/76 PEO/POP/PEO) [42,43].
The search for non-biocidal molecules is increasingly being
eported in the literature, ranging from molecules and potential
urfaces coatings up to more aggressive strategies such as the use
f bacteriophages. In this sense, attempts to impregnate/cover the
olystyrene surface with Pluronic F127 were made.
It is known theoretically that triblocked copolymer physical
dsorption to surfaces shows reversibility characteristics [38]. In
his sense, we attempted to covalently bind the surfactant to the
urface with a previous argon plasma surface discharge activation
rocess followed by a surfactant impregnation process. Further,
fter the treatments, successive washes of the surface were per-
ormed in order to evaluate impregnation stability (Table S4).ience 303 (2014) 147–154
Polymeric biomaterials plasma modiﬁcation afford to obtain
better properties in terms of biocompatibility, without alteration
of the bulk material itself [42]. Argon plasma discharge was  used in
order to create reactive sites for subsequent surfactant anchoring.
Argon is a noble inert gas, so it does not react with the material, but
by being accelerated against the surface it is capable of abrading
the surface layers, increasing the surface roughness and creating
reactive sites [43,44].
As can be observed in Table S4, when all washing frequencies are
compared to each other, for the treatment and control, there were
no differences in bioﬁlm formation and bacterial growth. How-
ever, when comparing the bioﬁlm formation data for the control to
the treatment, there were signiﬁcant differences in the three fre-
quencies of washes. So it was clear that plasma ionic pretreatment
makes the polystyrene surface more prone to bioﬁlm formation.
Thus, there is no need of using plasma ionic surface activation as a
methodology prior to impregnation, under the working conditions
applied in this study. It is suggested that the increased propensity
for bioﬁlm formation is a consequence of the increase in surface
roughness during plasma processing [44]. It is noted that in sim-
ilar studies on this subject surfaces coatings were not submitted
to washing procedures. In this sense, we  can consider our results
satisfactory, since even after 150 wash steps antibioﬁlm formation
activity was  compromised to only 30% for the untreated control.
Sheu et al. [45] evaluated an argon plasma discharge on polyeth-
ylene surfaces previously coated with pluronics, an inverse process
in comparison to the applied in this work. It was suggested that the
copolymers tested were covalently bound to the polyethylene sur-
face. However, plasma untreated controls were not cited, which
raises doubts about the real applicability of the process.
Bridgett et al. [25] tested a simple coating of polystyrene sheets
using various Pluronics, including F68 and F127. The technique
showed anti-adhesive properties of the copolymers against Staphy-
lococcus clinical strains. Based on this report and the results above, it
was decided to attempt to carry out a direct impregnation of Pluron-
ics F68 and F127 on the polystyrene surface followed by washing
experiments.
These efforts encompassed two impregnation methods, which
resulted in: (1) bathed surface in aqueous surfactant solution and
(2) dry surface (simple deposition) using 96% ethanol, a volatile
solvent as surfactant dispersant. It is suggested, in both cases, that
the surfactant strongly adsorbs to the polystyrene surface. There
were no signiﬁcant differences between trials impregnation (1) and
(2) of Pluronic F127 at concentrations ranging from 0.003 to 0.1%
for both antibioﬁlm formation and antibiotic activity (Fig. 2).
Independently of the concentration or the impregnation method
used, the results were very similar to each other, showing no signif-
icant differences according to Student’s t test, p < 0.05. Antibioﬁlm
formation activity was  retained, as well as non-biocidal charac-
teristics, as previously described in a study that highlighted the
anti-fouling effects of Pluronic F127at concentrations ranging for 1
to 2% [46].
The results obtained by the crystal violet and OD600 method-
ologies for both Pluronic F127 impregnations could be clearly
corroborated and observed by scanning electron microscopy under
PERMANOXTM, a hydrophobic surface model as shown in Fig. 3.
As can be seen in Figure S1, Pluronic F127 did not inhibit bioﬁlm
formation on a hydrophilic surface, such as glass, on the same
scale that inhibits on hydrophobic PERMANOXTM. Schroen and
coworkers [47] have suggested that the conformation of the tri-
block copolymer adsorbed to a surface is dependent on the surface
polarity. It is believed that copolymers adsorbed on hydrophobic
surfaces result in a conformation “brush”, where the POP chain
is anchored to the surface. On a hydrophilic surface, the PEO
chains terminal adheres to the surface, forming a conformation
called “pancake” phenomenon, previously exploited by Nedjanik
J. Treter et al. / Applied Surface Science 303 (2014) 147–154 151
Fig. 1. Staphylococcus epidermidis clinical strains bioﬁlm formation (black bars) and bacterial growth (hatched bars) exposed to 0.1% (a) Pluronic F68 and (b) Pluronic F127.
Data  are means of three separate experiments, each with six replicates for each treatment.
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sig. 2. Comparison of impregnation methods: (1) aqueous solution (black bar) and
re  means of three separate experiments, each with six replicates for each treatmen
t al. [48], where hydrophobicity thresholds on which the Pluronic
127 conformation becomes from “pancake” to “brush” were
valuated.
Pluronic F68 behavior was evaluated in both biomaterial sur-
aces, hydrophilic and hydrophobic, due to belong to the same class
f F127. Pluronic F68 is a more polar surfactant. So, given the greater
roportion of PEO chains relative to POP, as compared to F127, its
onformation may  be different. The “brush” conformation of PEO
hains creates better anti-adhesive properties than the “pancake”
onformation. It is known that a contact angle of a water droplet
n the surface should be greater than 80  in order that the “brush”
hape is achieved [l].
ig. 3. Staphylococcus epidermidis bioﬁlm formation photomicrographs on PERMANOXTM
olution in different concentrations: (a) untreated; (b) 0.003%; (c) 0.025%; (d) 0.1%.hanolic solution (white bars). (a) Bioﬁlm formation and (b) Bacterial growth. Data
st: p < 0.05.
As previously observed in the screening results, Pluronic F68 did
not inhibit bioﬁlm formation on the polystyrene surface, as can be
seen in Section (1) of the photomicrographs (Figure S2).
Due to differences in the results of the Pluronic F127 on the
surface models, hydrophobic and hydrophilic, it was  decided to
assess the inﬂuence of the biomaterial surface polarity also for
F68. It is suggested, according to photomicrographies presented
in (2) of Figure S2, that, depending of the Pluronic F68 concentra-
tion applied, antibioﬁlm formation activity could be observed on
the glass hydrophilic surface.
In solution, surfactants tend to achieve a minimum free energy
state. When they are at low concentrations their monomer units
surface impregnated with Pluronic F127 with: (1) aqueous solution; (2) ethanolic
152 J. Treter et al. / Applied Surface Science 303 (2014) 147–154
Fig. 4. Bioﬁlm formation on polystyrene surface impregnated with 0.14% (black
bars), 0.68% (grey bars) and 3.4% (white bars) of Pluronic F127 washed in a growing
number of times with MilliQ water (smooth bars) or PBS pH 7.4 (hatched bars). Data
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re located spontaneously at the surface/interface in order to
emove the hydrophobic portion of the molecule from the aque-
us medium. As there is an increase in the surfactant concentration
n solution, surface saturation occurs followed by bulk saturation,
nd the decrease in free energy is achieved by formation of micelles.
he concentration at which micelle formation is initiated is called
ritical Micellar Concentration (CMC) [49]. To certify that we were
orking with the same pattern in terms of monomer density at
he surface for Pluronic F68 and F127, CMC  was experimentally
stimated; since it was not found in literature, CMC  values were
etermined by the same method and temperature for both surfac-
ants. For Pluronic F68 the CMC  value obtained was equal to 0.81%
0.96 mM)  and to 0.68% (0.56 mM)  for F127, at room temperature.
lexandridis et al. [50] described a CMC  of 0.7% (0.555 mM)  at 25 ◦C
or Pluronic F127, a very similar value to that determined in this
ork. To evaluate CMC  interference in S. epidermidis antibioﬁlm
ormation upon polystyrene, the impregnation method (2) was
pplied, and the surface was covered with concentrations below
nd above Pluronic F127 CMC.
According to Fig. 4, it can be seen that there is no signiﬁcant dif-
erence between all concentrations tested, either above or below
he CMC. It is suggested that a complete surface saturation that
s afforded by the formation of micelles, were not necessary to
rovide the anti-adhesive activity under the conditions used in
his study. Further, it can be clearly seen that the washings had
o effect on bioﬁlm formation inhibition, regardless of the wash-
ng liquid used, MilliQ water or PBS. Thus, it is believed that a strong
seudo-irreversible adsorption of Pluronic F127 apolar portion to
ig. 5. Staphylococcus epidermidis bacterial growth/bioﬁlm formation photomicrographs o
ith  Pluronic F127: (a) control; (b) 0.14%; (c) 0.68%; (d) 3.4%; (1) without wash, (2) 100×Fig. 6. Effect of different surfactant concentrations on the cell surface hydrophobic-
ity.  S. epidermidis HPBI with> 70% was  arbitrarily classiﬁed as hydrophobic.
the polystyrene occurs [51]. It is suggested that the proportion of
the nonpolar portion over the polar is responsible for the phe-
nomenon of 90% of inhibition of S. epidermidis bioﬁlm formation
observed as well as the size of the polar portion which should be
large enough to generate a protective barrier. F127 has a larger apo-
lar portion regarding F68, thus, occurring higher bonding strength
with the apolar solid substrate (polystyrene) and also has larger
polar portion which allows the formation of polymeric brushes
differently from the report that suggest different behaviors just
because of the difference in nonpolar chain length between the F68
and F27 [52]. The results of the washing are conﬁrmed by electron
microscopy images (Fig. 5).
As can be observed in Fig. 5(a) the untreated control, bioﬁlm for-
mation is extensive on the polystyrene surface. In the treatments at
all concentrations tested (b-d), and after many washings (1-3), the
presence of bacterial aggregates or even single cells is considerably
less frequent, ensuring suitability of the coating process.
In order to strengthen the hypothesis that the surfactant adsorbs
to the polystyrene surface, the surfactant inﬂuence on the S. epider-
midis surface was measured by determining bacterial cell surface
hydrophobicity index (HPBI).
Once no concentration of Pluronic F127 altered the bacteria
cell surface polarity, from 0.003% to CMC  (0.68%) and remained
similar to the untreated control (Fig. 6), it is suggested that the
S. epidermidis antibioﬁlm formation activity upon polystyrene is
due to the surfactant binding to the material surface. The bacte-
rial pathogen surface, untreated or treated, remained hydrophobic,
with a HPBI > 80%. This result corroborates previous literature data
n PERMANOXTM surface impregnated according to method (2) (ethanolic solution)
 MilliQ water washes and (3) 100× PBS washes.
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Table  1
Water contact angle, drop image and average roughness obtain from atomic force images on the polystyrene surface impregnated with Pluronic F127 by method (2).
Pluronic F127 concentration Water contact angle () Drop image Average roughness (nm)
Control 99.6 ± 2.0 1.9 ± 0.2
CMC/5 25.1 ± 1.2 2.0 ± 0.3
CMC  53.3 ± 0.7 3.3 ± 0.2
CMCx5 65.9 ± 0.6 3.6 ± 0.2
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mum pretreatment with Pluronic F127 0.1% over polystyrene surface, in two contact
eriods, 6 and 24 h.
hat have suggested that adherence to solid surfaces is controlled
rimarily by changes in the solid surface hydrophobicity, rather
han on the cell surface hydrophobicity [53].
In order to measure the physical effect of Pluronic F127 on
he material surface, the surfactant ability to interfere with S. epi-
ermidis bioﬁlm formation phenotype was estimated by bacterial
noculum prior exposure to 0.1% of the surfactant and subsequent
valuation of the bioﬁlm forming capacity (Fig. 7).
In the absence or presence of Pluronic F127 as the inoculum
rior treatment, two treatment periods, 6 and 24 h, bacterial cells
ere shown to form bioﬁlms normally. The result was similar to
he untreated control cells (absence) which manipulation was  per-
ormed exposed to water instead of Pluronic F127.
Overall, the results suggest a physical phenomenon of interfer-
nce of the Pluronic F127 against S. epidermidis bioﬁlm formation
n the polystyrene surface. It is well accepted in the scientiﬁc
iterature that the physicochemical properties of the substrate
urface/material are the main factors that mediate the bacte-
ial adhesion [54]. Among them, it is suggested that the surface
ree energy (surface hydrophobicity) and roughness are the main
arameters responsible for the adhesion of bacteria to the surface
57,56].
Accordingly, for the material surface physical characterization
ere performed atomic force microscopy to determine the sur-
ace roughness and contact angle measurements to estimates the
urface hydrophobicity (Table 1 and Figure S3).
It is observed in Table 1 that the impregnation applied in this
ork has made the polystyrene surface hydrophilic to varying
egrees. At surfactant concentrations of 0.14 (CMC/5), 0.68 (CMC)
nd 3.4% (CMCx5) there was a contact angles change of approxi-
ately 100  to 25, 53 and 66 , respectively.In terms of solid-air interface, it is suggested that from the
moment the surfactant monomers saturate the surface (which
would tend to form micellar aggregates in solution), the nonpo-
lar surfactant portion is forced to arrange the surface. This fact
triggers an increase in hydrophobicity higher than the surfactant
concentration, 25.1 (CMC/5) to 65.9  (CMCx5).
Previous work indicated that the roughness parameter overrides
the effect of surface hydrophobicity in adhesion [57,56], although it
remains controversial, as roughness parameter may  not inﬂuence
bacterial adhesion [57]. An increase in roughness with increas-
ing surfactant concentration can be observed in table 2; however,
under the conditions applied in this work, roughness does not seem
to interfere with bacterial adhesion.
4. Conclusions
The chemical surfactant Pluronic F127 showed signiﬁcant activ-
ity against the adherence of S. epidermidis upon hydrophobic
polystyrene surface, without causing the microorganism death. It
is believed that the non adherent characteristic of Pluronic 127 is
due to the formation of polymeric brushes on the material surface.
The proportion of PEO and POP in the surfactant composition and
the material surface polarity seem to affect the activity. A directly
impregnation of the surface resulted in a 90% of antibioﬁlm for-
mation activity, even after 100 consecutive washings, indicating
a strong physical adsorption of Pluronic F127 to the polystyrene
surface. Pluronic F127 did not alter the S. epidermidis surface polar-
ity, and does not seem to inﬂuence the pathogen phenotype of
bioﬁlm formation. This paper presents a simple method for coating
employing a synthetic surfactant, with signiﬁcant evidence of sta-
bility, to prevent bioﬁlm formation of S. epidermidis on the surface
of hydrophobic materials such as polystyrene. Thus, it represents
a set of promising results in the ﬁeld of biomaterials and hospital
infections.
Acknowledgments
The authors are grateful to the Brazilian National Council for
Research and Development (CNPq/Brazil). FAPERGS (Brazil) and
CAPES NANOBIOTEC (Brazil) for scholarships and ﬁnancial support.
Appendix A. Supplementary dataSupplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.apsusc.2014.02.123.
1 ace Sc
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[54 J. Treter et al. / Applied Surf
eferences
[1] E. Karunakaran, J. Mukherjee, B. Ramalingam, C.A. Biggs, Appl. Microbiol.
Biotech. 90 (2011) 1869–1881.
[2] U. Römling, C. Balsalobre, J. Int. Med. 272 (2012) 541–561.
[3] “Research on microbial bioﬁlms (PA-03-047)”. NIH, National Heart, Lung, and
Blood Institute, 2002-12-20.
[4] N.Y.A. Aly, H.H. Al-Mousa, E.S.M.A. Asar, Med. Princ. Pract. 17 (2008) 373–377.
[5] M.  Otto, Nat. Rev. Microbiol. 7 (2009) 555–567.
[6] R.P. Wenzel, Clin. Infect. Dis. 45 (2007) S85–S88.
[7] J. Treter, A.J. Macedo, in: A. Méndez-Vilas (Ed.), Science against Microbial
Pathogens: Communicating Current Research and Technological Advances,
Formatex Research Center, 2011, pp. 835–842.
[8] J.W. Costerton, L. Montanaro, C.R. Arciola, Int. J. Artif. Organs 28 (2005)
1062–1068.
[9] A. Roosjen, H.J. Busscher, W.  Norde, H. van der Mei, Microbiology 152 (2006)
2673–2682.
10] J.W. Costerton, P.S. Stewart, E.P. Greenberg, Science 284 (1999) 1318–1322.
11] R.M. Donlan, Emerg. Infect. Dis. 8 (2002) 881–890.
12] D. Davies, Nat. Rev. Drug Discov. 2 (2003) 114–122.
13] N. Høiby, T. Bjarnsholt, M.  Givskov, S. Molin, O. Ciofu, Int. J. Antimicrob. Agents
35 (2010) 322–332.
14] C.M. Toutain-Kidd, S.C. Kadivar, C.T. Bramante, S.A. Bobin, M.E. Zegans, Antimi-
crob. Agents Chemother. 53 (2009) 136–145.
15] A.L.S. Antunes, J.W. Bonfanti, L.R.R. Perez, C.C.F. Pinto, A.L.P. Freitas, A.J. Macedo,
A.L. Barth, Mem.  Inst. Oswaldo Cruz 106 (2001) 51–55.
16] K. Toté, D.V. Berghe, M.  Deschacht, K. de Wit, L. Maes, P. Cos, J. Antimicrob.
Agents 33 (2009) 525–531.
17] W.  Senaratne, L. Andruzzi, C.K. Ober, Biomacromolecules 6 (2005) 2427–2448.
18] A. Foka, M.G. Katsikogianni, E.D. Anastassiou, I. Spiliopoupou, Y.F. Missirlis, Eur.
Cell. Mater. 24 (2012) 386–402.
19] F.D. Matl, A. Obermeier, S. Repmann, W.  Friess, A. Stemberger, K.D. Kuehn,
Antimicrob. Agents Chemother. 52 (2008) 1957–1963.
20] Y. Su, L. Wang, X. Yang, Appl. Surf. Sci. 254 (2008) 4606–4610.
21] Q. Tu, J.C. Wang, R. Liu, J. He, Y. Zhang, S. Shen, J. Xu, J. Liu, M.S. Yuan, J. Wang,
Colloid Surf. B 102 (2013) 361–370.
22] J.D. van Hamme, A. Singh, O.P. Ward, Biotechnol. Adv. 24 (2006) 604–620.
23] T.R. Neu, Microbiol. Rev. 60 (1996) 151–166.
24] A. Singh, J.D. van Hamme, O.P. Ward, Biotechnol. Adv. 25 (2007) 99–121.
25] M.J. Bridgett, M.C. Davies, S.P. Denyer, Biomaterials 13 (1992) 411–416.
26] D. da, S. Trentin, R.B. Giordani, K.R. Zimmer, A.G. da Silva, M.V. da Silva, M.T.
Correia, I.J. Baumvol, A.J. Macedo, J. Ethnopharmacol. 137 (2011) 327–335.
27] S.G. Verza, P.E. Resende, S. Kaiser, L. Quirici, H. Teixeira, G. Gosmann, F. Ferreira,
G. G. Pharmazie 67 (2012) 288–292.
28] S. Limsuwan, S.P. Voravuthikunchai, FEMS Immunol. Med. Microbiol. 53 (2008)429–436.
29] A. Nostro, M.A. Cannatelli, G. Crisaﬁ, A.D. Musolino, F. Procópio, V. Alonzo, Lett.
Appl. Microbiol. 38 (2004) 423–427.
30] O. Rendueles, L. Travier, P. Latour-Lambert, T. Fontaine, J. Magnus, E. Denamur,
J.  Ghigo, MBio 2 (2011), e00043-1.
[
[ience 303 (2014) 147–154
31] J. Castro-Garza, H.B. Barrios-García, D.E. Cruz-Vega, S. Said-Fernández, P.
Carranza-Rosales, C.A. Molina-Torres, L. Vera-Cabrera, J. Med. Microbiol. 56
(2007) 733–737.
32] E. Blondel-Hill, D.A. Henry, D.P. Speert, Manual of Clinical Microbiology, ninth
ed., ASM Press, Washington, 2007.
33] M.  Souli, I. Galani, H. Giamarellou, Eurosurveillance 13 (2008) 1–11.
34] M.R. Nejadnik, H.C. van der Mei, W.  Norde, H.J. Busscher, Biomaterials 29 (2008)
4117–4121.
35] K. Lewis, Ann. Rev. Microbiol. 64 (2010) 357–372.
36] M.  Otto, Annu. Rev. Med. 64 (2013) 1–14.
37] N. Ayres, Polym. Chem. 1 (2010) 769–777.
38] J.E. Raynor, J.R. Capadona, D.M. Collard, T.A. Petrie, A.J. García, Biointerphases 4
(2009) FA3–FA16.
39] A. Roosjen, W.  Norde, H. van der Mei, H.J. Busscher, Prog. Colloid Polym. Sci.
132 (2006) 138–144.
40] D. da, S. Trentin, D.F. Gorziza, W.R. Abraham, A.L.S. Antunes, C. Lerner, B. Mothes,
C.  Termignoni, A.J. Macedo, Braz. J. Microbiol. 42 (2011) 1329–1333.
41] A. Roosjen, H. van der Mei, H.J. Busscher, W.  Norde, Langmuir 20 (2004)
10949–10955.
42] T. Jacobs, R. Morent, N. Geyter, P. Drubuel, C. Leys, Plasma Chem. Plasma P 32
(2012) 1039–1073.
43] R.M. France, R.D. Short, Langmuir 14 (1998) 4827–4835.
44] R.L. Bruce, F. Weilnboeck, T. Lin, R.J. Phaneuf, G.S. Oehrlein, B.K. Long, C.G. Will-
son, J.J. Vegh, D. Nest, D.B. Graves, J. Appl. Phys. 107 (2010), 084310-084310-5.
45] M.S. Sheu, A.S. Hoffman, J. Feijen, J. Adhes. Sci. Technol. 6 (1992) 995–1009.
46] L.H. Marsh, M. Coke, P.W. Dettmar, R.J. Ewen, M.  Havler, T.G. Nevell, J.D. Smart,
J.R. Smith, B. Timmins, J. Tsibouklis, C. Alexander, J. Biomed. Mater. Res.: A 61
(2002) 641–652.
47] C.G.P.H. Schroen, M.A. Cohen Stuart, K. van der Voort Maarschalk, A. van der
Padt, K. van’t Riet, Langmuir 11 (1995) 3068–3074.
48] M.R. Nejadnik, A.L.J. Olsson, P.K. Sharma, H.C. van der Mei, W.  Norde, H.J. Buss-
cher, Langmuir 25 (2009) 6245–6249.
49] A.T. Florence, D. Attwood, in: A.T. Florence, D. Attwood (Eds.), Princípios físico-
químicos em farmácia, Ed. da Universidade de São Paulo, São Paulo, 2003, pp.
279–343.
50] P. Alexandridis, J.F. Holzwarth, T.A. Hatton, Macromolecules 27 (1994)
2414–2425.
51] J.T. Li, J. Carlsson, J.N. Lin, K.D. Caldwell, Bioconjugate Chem. 7 (1996)
592–599.
52] Y.B. Liou, R.Y. Tsay, J. Taiwan Inst. Chem. Eng. 42 (2011) 533–540.
53] D.G. Brown, P.R. Jaffé, Environ. Sci. Technol. 40 (2006) 195–201.
54] E.P.J.M. Everaert, H.C. van der Mei, H.J. BUSSCHER, Colloid Surf. B 10 (1998)
179–190.
55] M.  Quirynen, M.  Marechal, H.J. Busscher, A.H. Weerkamp, P.L. Darius, D.
Vansteenberghe, J. Clin. Periodontol. 17 (1990) 138–144.
56] H. Tang, T. Cao, X. Liang, A. Wang, S.O. Salley, J. Mcallister II., K.Y.S. Ng, J. Biomed.
Mater. Res.: A 88 (2009) 454–463.
57] A. Hook, C.Y. Chang, J. Yang, J. Luckett, A. Cockayne, S. Atkinson, Y. Mei, R.
Bayston, D.J. Irvine, R. Langer, D.G. Anderson, P. Williams, M.C. Davies, M.R.
Alexander, Nat. Biotechnol. 30 (2012) 868–875.
